CG ONCOLOGY INC (CGON)
NASDAQ • Healthcare
$76.29
-$0.81 (-1.1%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About CG ONCOLOGY INC
Name
CG ONCOLOGY INC
CEO
Arthur Kuan
Website
Industry
Healthcare
Year Founded
2010
Employees
142
CG Oncology Inc. is a U.S. biotechnology company listed on NASDAQ under the ticker CGON that develops bladder-cancer therapies. In qualitative terms, it is a clinical-stage healthcare business centered on cretostimogene grenadenorepvec, also referred to as cretostimogene, an investigational oncolytic immunotherapy.
Fundamentals & Financials
Revenue (TTM)
$6.2M
Net Income (TTM)
-$224.3M
EPS (TTM)
-$2.7
ROA (TTM)
-20.67%
Current Ratio
22.22
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$76.29$75.31 - $77.5
52 Week RangeAvg. Volume$24.85 - $79.39789.7K
Market Cap$6.7B
Peers & Related Assets
APGEAPOGEE THERAPEUTICS INC
$134.57-0.0%
XENEXENON PHARMACEUTICALS INC
$63.18+1.3%
TVTXTRAVERE THERAPEUTICS INC
$63.9+0.6%
CELCCELCUITY INC
$93.24+0.9%
IRONDISC MEDICINE INC
$80.2+0.2%
TARSTARSUS PHARMACEUTICALS INC
$71.03+0.6%
RAREULTRAGENYX PHARMACEUTICAL INC
$25.49-2.5%
CNTACentessa Pharmaceuticals plc
LEGNLegend Biotech Corporation
AAPGAscentage Pharma Group International